We are live on ! Find out more
KALA icon

KALA BIO

112 hedge funds and large institutions have $248M invested in KALA BIO in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 23

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

7% more funds holding

Funds holding: 105112 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less ownership

Funds ownership: 0.03%0.03% (-0%)

11% less call options, than puts

Call options by funds: $3.29M | Put options by funds: $3.7M

12% less capital invested

Capital invested by funds: $283M → $248M (-$35M)

Holders
112
Holders Change
+7
Holders Change %
+6.67%
% of All Funds
1.98%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
36
Reduced
23
Closed
18
Calls
$3.29M
Puts
$3.7M
Net Calls
-$409K
Net Calls Change
+$1.85M
Name Holding Trade Value Shares
Change
Change in
Stake
CS
51
Credit Suisse
Switzerland
$267K +$113K +6 +60%
Nisa Investment Advisors
52
Nisa Investment Advisors
Missouri
$252K +$245K +13 +650%
AC
53
Athanor Capital
New York
$249K +$94.1K +5 +50%
T. Rowe Price Associates
54
T. Rowe Price Associates
Maryland
$238K +$151K +8 +133%
CAM
55
ClariVest Asset Management
California
$225K
D.E. Shaw & Co
56
D.E. Shaw & Co
New York
$221K +$56.4K +3 +30%
Deutsche Bank
57
Deutsche Bank
Germany
$204K +$56.4K +3 +33%
CL
58
CSS LLC
Illinois
$198K +$18.8K +1 +9%
BC
59
Bridgefront Capital
Texas
$192K +$207K +11 New
AC
60
Aristides Capital
Kentucky
$176K +$188K +10 New
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$174K
TWMP
62
Taylor Wealth Management Partners
Massachusetts
$174K +$75.3K +4 +67%
Group One Trading
63
Group One Trading
Illinois
$160K +$132K +7 +350%
New York State Common Retirement Fund
64
New York State Common Retirement Fund
New York
$155K -$113K -6 -40%
WS
65
Wedbush Securities
California
$153K -$1.15M -61 -87%
Principal Financial Group
66
Principal Financial Group
Iowa
$150K +$169K +9 New
DekaBank Deutsche Girozentrale
67
DekaBank Deutsche Girozentrale
Germany
$143K +$151K +8 New
BAM
68
Blueshift Asset Management
New Jersey
$139K +$151K +8 New
AQR Capital Management
69
AQR Capital Management
Connecticut
$138K -$113K -6 -43%
GWM
70
Greenwich Wealth Management
Connecticut
$138K +$18.8K +1 +14%
CLOS
71
Compagnie Lombard Odier SCmA
Switzerland
$136K +$151K +8 New
MIM
72
MetLife Investment Management
New Jersey
$128K
VOYA Investment Management
73
VOYA Investment Management
Georgia
$124K +$18.8K +1 +17%
Commonwealth Equity Services
74
Commonwealth Equity Services
Massachusetts
$120K +$37.6K +2 +40%
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$118K

KALA Hedge Fund Activity: Q4 2020 in Review

112 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2020, worth a combined $248M — down 12% from $283M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new KALA positions and 18 closed out — a net gain of 7 holders — while 36 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $4.46M. The largest seller was Fidelity Investments, cutting an estimated $20.9M.

  • 112 institutional investors held KALA BIO (KALA) as of Q4 2020, up from 105 in Q3 2020.
  • Funds reported $248M of KALA BIO stock for Q4 2020, down 12% quarter-over-quarter.
  • 25 funds opened new KALA BIO positions in Q4 2020 and 18 closed out, a net change of +7 holders.
  • The largest KALA BIO buyer in Q4 2020 was BlackRock, an estimated $4.46M added.
  • The largest KALA BIO seller in Q4 2020 was Fidelity Investments, an estimated $20.9M sold.

Based on aggregated 13F filings for Q4 2020.